Cita APA (7a ed.)

NE, G., MN, R., L, R., & F, I. (2019). SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: Pathophysiology, clinical outcomes, and future directions. Dove Medical Press.

Cita Chicago Style (17a ed.)

NE, Gharaibeh, Rahhal MN, Rahimi L, y Ismail-Beigi F. SGLT-2 Inhibitors as Promising Therapeutics for Non-alcoholic Fatty Liver Disease: Pathophysiology, Clinical Outcomes, and Future Directions. Dove Medical Press, 2019.

Cita MLA (8a ed.)

NE, Gharaibeh, et al. SGLT-2 Inhibitors as Promising Therapeutics for Non-alcoholic Fatty Liver Disease: Pathophysiology, Clinical Outcomes, and Future Directions. Dove Medical Press, 2019.